
Loading, please wait...

Loading, please wait...

Specialty diagnostics in India are currently undergoing a significant transformation as major players pivot toward precision medicine. Metropolis Healthcare is leading this change by focusing heavily on genomics and next-generation sequencing. This shift aims to meet the evolving needs of clinicians and patients across the country. Consequently, the company plans to deepen its presence in over 750 cities to enhance diagnostic accessibility.
Ameera Shah, Executive Chairperson of Metropolis, highlights that genomics will define the next decade of medical diagnostics. Currently, specialty testing contributes nearly 40% of the company's total revenue. Furthermore, this segment is growing much faster than routine pathology services. This trend is particularly evident in high-growth therapeutic areas such as oncology and neurology. Moreover, next-generation sequencing helps doctors accurately diagnose diseases and guide specific therapies for complex conditions.
The diagnostic giant is also reimagining its physical centers beyond traditional pathology. For example, they have piloted services like X-rays, ECGs, and sonography in various locations. By scaling these models, the company aims to provide a comprehensive health check-up ecosystem. This transition reflects a broader industry move toward integrated preventive healthcare services. Therefore, improving productivity from existing assets remains a top operational priority for the management team.
Metropolis intends to complete four to five strategic acquisitions over the next three years. However, these deals must happen at sensible valuations with high-quality businesses. While the primary strategy remains organic growth, acquisitions help strengthen their regional presence in northern Indian markets. Additionally, they seek to acquire scientifically strong assets that add specialized expertise to their portfolio. Success over the next 24 months will depend on maintaining steady organic growth and sustainable margins.
Q1: Why is Metropolis Healthcare focusing on next-generation sequencing?
Next-generation sequencing is critical for precision diagnostics in oncology and neurology. It allows doctors to choose the most effective therapies based on a patient's unique genetic profile.
Q2: What is the expected revenue contribution from specialty diagnostics?
Metropolis expects specialty diagnostics to contribute approximately 45% of their total revenue in the coming years, up from the current 38-39%.
Q3: How many cities does Metropolis Healthcare currently operate in?
The company has expanded its operations from 300 cities to nearly 750 cities over the last three years, significantly increasing its diagnostic reach.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice or replace professional judgment. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


Metropolis Healthcare is betting on genomics, next-gen sequencing, and strategic acquisitions to lead the specialty diagnostics market in India by 2026....
2 months ago

Andhra Pradesh reported 10 new Covid-19 cases, taking the state tally to 49 while deaths remain at four. With 24 patients hospitalized and 16 under home isolation, the Health Department has intensified monitoring. Medical professionals should review regional distribution, diagnostic protocols, and management plans.
Today

An 11-year Swedish registry study of 618 uterine sarcoma patients found that minimally invasive surgery yielded survival comparable to open surgery in early stages. However, adjuvant chemotherapy conferred no survival benefit in localized or advanced disease, highlighting stage and histology as key outcomes.
3 days back

A cross-sectional study evaluates post-intensive care syndrome in cardiac patients 2-4 weeks post-ICU discharge, highlighting cognitive, psychological, and functional impairments and the need for structured multidisciplinary rehabilitation.
3 days back

Anterior cruciate ligament reconstruction failure lacks uniform definition. A narrative review proposes an integrative framework incorporating objective and subjective instability, persistent pain, restricted motion, graft rupture, and secondary meniscal injury to standardize clinical reporting.
3 days back

With World Obesity Atlas data warning that over 41 million Indian children are overweight or obese, ICMR and NIN have unveiled a 10-point policy roadmap. The initiative calls for mandatory front-of-pack labeling, HFSS taxes, strict marketing bans, and healthier school environments to curb non-communicable diseases.
Today